Vaginal Slings Market Size was valued at USD 1.45 Billion in 2023. The vaginal slings market industry is projected to grow from USD 1.62 Billion in 2024 to USD 3.69 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.77% during the forecast period (2024 - 2032).
The prevalence of stress urine incontinence is on the rise, and the number of elderly women in the female population is rising as well. These are the main market drivers driving the market share for vaginal slings. Additionally, market participants' intense interest in the creation of technologically improved vaginal slings has increased demand for the sector and propelled the expansion of the vaginal slings market.
Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
November 2021: Hologic has disclosed its intention to introduce the NovaSure V5 global endometrial ablation (GEA) device for treating abnormal uterine bleeding at the forthcoming American Association of Gynecologic Laparoscopists (AAGL) 50th Global Congress, which will be held both virtually and in-person from November 14-17 in Austin, Texas. This information was conveyed in a press release issued by the company. The NovaSure system received first approval from the U.S. Food and Drug Administration in 2001 and has been utilized in the treatment of more than 3 million patients as of 2018. The equipment is specifically engineered to enhance the comfort and dexterity of physicians, while also being capable of accommodating various widths of the cervical canal. The NovaSure V5 device is a cutting-edge invention that builds upon a 20-year track record of unparalleled performance and incorporates improvements based on valuable consumer input. Hologic's GYN Surgical Solutions division maintains its dedication to prioritizing physicians and the women they care for by actively seeking and incorporating their feedback into the development of new innovations. Their constant endeavor is to collaborate with physicians in order to attain superior results for ladies.
The market for vaginal slings is anticipated to increase in the future due to the rising number of elderly women. The senior population (65 years and over) is referred to as the female geriatric population. Vaginal slings are used to treat and control stress urine incontinence (SUI), which affects a section of the expanding female geriatric population. For instance, women made up 55% of the population aged 65 or over in October 2020, according to World Population Ageing 2020 Highlights, issued by the United Nations, a US-based intergovernmental organization. They currently account for 62% of those who are 80 or older. According to predictions, the proportion of elderly persons in the population would increase from 9.3% in 2020 to 16.0% in 2050. Therefore, the market CAGR for vaginal slings is expected to develop in the future due to the rising number of elderly women.
The creation of technologically sophisticated vaginal slings is a crucial trend that is becoming more and more popular in the vaginal sling market. To maintain their position in the vaginal sling industry, major firms are creating vaginal slings that are technologically advanced. For instance, US-based Caldera Medical, a maker of medical equipment, debuted Desara One in May 2020. It is a blue one incision sling system with completely integrated mesh for female stress urine incontinence that helps to reduce mesh roping, twisting, and ripping while maximizing connection strength. This innovative device is streamlined with an anchor-mesh transition that is made to lay flat under the urethra and is intended to lessen tissue injury and dissection. Thus, driving the vaginal slings market revenue.
The vaginal slings market segmentation, based on method includes Retropubic Method, Transobturator Method and Others. The transobturator method segment dominated the market due to their lower risk of causing significant blood vessel, bladder, or intestine damage, ease of use, and effectiveness comparable to tension-free vaginal tape slings. For instance, single-incision mini-slings are a secure and reliable treatment for female urodynamic stress incontinence, according to a Pubmed article from November 2021. According to this study, the Solyx single-incision slings outperformed the MiniArc due to their better objective cure rate and lower chance of surgical failure. Transobturator sling benefits will therefore spur market expansion in the future.
The vaginal slings market segmentation, based on type, includes Tension-Free Vaginal Tape Slings and Others. The tension-free vaginal tape slings category generated the most income due to manufacturers' increasing interest in creating items like vaginal mesh and vaginal micro slings to address urine incontinence. Additionally, tension-free vaginal tape slings are widely used since they are secure, less invasive, and quick to complete.
Figure 1: Vaginal Slings Market, by Type, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
The vaginal slings market segmentation, based on end user, includes Hospitals, Ambulatory Surgical Centers and others. The hospitals category generated the most income as a result of the significant deployment of minimally invasive robotic surgery in hospital settings. With the goal of assisting rural hospitals and promoting the rehabilitation and building of rural healthcare institutions, the Biden Administration issued $500 million in American Rescue Act grants in 2021. These kinds of developments are also anticipated to drive the general market dynamics in the ensuing years, together with the gradually rising surgery rate in hospitals.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American vaginal slings market area will dominate this market because women in this area are more likely to suffer from stress urine incontinence due to the early adoption of innovative vaginal slings and increased prevalence. A growing prevalence of mixed incontinence in women and urgency incontinence in men was found to be related with heart failure among chronic diseases. Because of this, the market will rise in the future despite a growing prevalence of diseases.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: VAGINAL SLINGS MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Europe vaginal slings market accounts for the second-largest market share due to the UK's high rate of urinary tract infections among women. Nearly 3-6 million individuals in the UK suffer from urine incontinence, according to figures from the National Health Service. The demand for vaginal mesh sling treatments is expected to increase faster than expected due to the frequency of this condition and the development of cutting-edge tools for minimally invasive surgery. Further, the German vaginal slings market held the largest market share, and the UK vaginal slings market was the fastest growing market in the European region
The Asia-Pacific Vaginal slings Market is expected to grow at the fastest CAGR from 2023 to 2032 because of the large population base, rising disposable incomes, and increased patient knowledge of advanced urinary incontinence care. In addition, established insurance programs and the availability of cutting-edge healthcare infrastructure are a couple of the other elements driving the market in this area. Moreover, China’s vaginal slings market held the largest market share, and the Indian vaginal slings market was the fastest growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the vaginal slings market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, vaginal slings industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the vaginal slings industry to benefit clients and increase the market sector. In recent years, the vaginal slings industry has offered some of the most significant advantages to market. Major players in the vaginal slings market attempting to increase market demand by investing in research and development operations include A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy) and Promedon (Argentina).
Ethicon US LLC (Ethicon), a division of Johnson & Johnson, is a provider of medical equipment through its subsidiaries Ethicon Inc. and Ethicon Endo-Surgery Inc. It creates and sells surgical tools and devices. The company's main offerings include staplers, clip appliers, energy devices, trocars, hemostats, endocutters, endoscopic instruments, suturing devices, irrigation products, meshes, and allografts. Its products are used to treat colorectal, thoracic, and hernia disorders, cancer, and obesity during minimally invasive and open surgical procedures.
Coloplast A/S (Coloplast) creates, markets, and provides services related to ostomy, respiratory, continence, urology, skin, and wound care. Urisheaths, ostomy bags, urine bags, catheters, anal irrigation systems, sling goods, advanced foam dressings and hydrocolloid dressings for protection against pressure injuries and skin damage, as well as cleansers, skin protectants, moisturizers, anti-fungal, and hand cleansers, are some of its main products. SenSura, SpeediCath, Persiteen, Conveen, InterDry, Biatain, Brava, and Comfeel are just a few of the brands that the business sells its goods under.
North America
Europe
Asia-Pacific
Rest of the World
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 1.45 Billion |
| Market Size 2024 | USD 1.62 Billion |
| Market Size 2032 | USD 3.69 Billion |
| Compound Annual Growth Rate (CAGR) | 10.77% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Method, Type, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy) and Promedon (Argentina) |
| Key Market Opportunities | Increasing disposable income |
| Key Market Dynamics | Increased healthcare spending and increasing awareness Rising number of elderly women |
Vaginal Slings Market Highlights:
Frequently Asked Questions (FAQ):
The vaginal slings market size was valued at USD 1.45 Billion in 2023.
The market is projected to grow at a CAGR of 10.77% during the forecast period, 2024-2032.
North America had the largest share in the market
The key players in the market are A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy) and Promedon (Argentina).
The transobturator method category dominated the market in 2023.
The hospitals category had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
